Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)

v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Voting Common Stock
Common Stock
Non-Voting Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2020   58,076,019 8,944,465    
Beginning balance at Dec. 31, 2020 $ (2,571) $ 1 $ 0 $ 9,577 $ (12,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)     2,086,829    
Stock-based compensation 4,942     4,942  
Net loss (9,398)       (9,398)
Ending balance (in shares) at Mar. 31, 2021   58,076,019 11,031,294    
Ending balance at Mar. 31, 2021 (7,027) $ 1 $ 0 14,519 (21,547)
Beginning balance (in shares) at Dec. 31, 2020   58,076,019 8,944,465    
Beginning balance at Dec. 31, 2020 (2,571) $ 1 $ 0 9,577 (12,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for debt modification 0        
Net loss (27,822)        
Ending balance (in shares) at Sep. 30, 2021   58,076,019 11,031,294    
Ending balance at Sep. 30, 2021 (25,451) $ 1 $ 0 14,519 (39,971)
Beginning balance (in shares) at Mar. 31, 2021   58,076,019 11,031,294    
Beginning balance at Mar. 31, 2021 (7,027) $ 1 $ 0 14,519 (21,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (7,590)       (7,590)
Ending balance (in shares) at Jun. 30, 2021   58,076,019 11,031,294    
Ending balance at Jun. 30, 2021 (14,617) $ 1 $ 0 14,519 (29,137)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (10,834)       (10,834)
Ending balance (in shares) at Sep. 30, 2021   58,076,019 11,031,294    
Ending balance at Sep. 30, 2021 (25,451) $ 1 $ 0 14,519 (39,971)
Beginning balance (in shares) at Dec. 31, 2021   86,344,881 0    
Beginning balance at Dec. 31, 2021 101,683 $ 9 $ 0 169,916 (68,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units, net (in shares)   120,876      
Stock-based compensation 11,042     11,042  
Net loss (25,772)       (25,772)
Ending balance (in shares) at Mar. 31, 2022   86,465,757 0    
Ending balance at Mar. 31, 2022 86,953 $ 9 $ 0 180,958 (94,014)
Beginning balance (in shares) at Dec. 31, 2021   86,344,881 0    
Beginning balance at Dec. 31, 2021 101,683 $ 9 $ 0 169,916 (68,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for debt modification 17,416        
Net loss (84,539)        
Ending balance (in shares) at Sep. 30, 2022   94,330,198 0    
Ending balance at Sep. 30, 2022 119,346 $ 9 $ 0 272,118 (152,781)
Beginning balance (in shares) at Mar. 31, 2022   86,465,757 0    
Beginning balance at Mar. 31, 2022 86,953 $ 9 $ 0 180,958 (94,014)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for business combination (in shares)   5,654,600      
Issuance of common stock for business combination 50,948     50,948  
Issuance of common stock for debt modification (in shares)   1,932,931      
Issuance of common stock for debt modification 17,416     17,416  
Issuance of common stock upon exercise of warrants (in shares)   10      
Vesting of restricted stock units, net (in shares)   115,166      
Stock-based compensation 11,783     11,783  
Net loss (31,663)       (31,663)
Ending balance (in shares) at Jun. 30, 2022   94,168,464 0    
Ending balance at Jun. 30, 2022 135,437 $ 9 $ 0 261,105 (125,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units, net (in shares)   161,734      
Stock-based compensation 11,013     11,013  
Net loss (27,104)       (27,104)
Ending balance (in shares) at Sep. 30, 2022   94,330,198 0    
Ending balance at Sep. 30, 2022 $ 119,346 $ 9 $ 0 $ 272,118 $ (152,781)